tranexamic acid has been researched along with Atypical Chronic Myeloid Leukemia in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Appelmann, I | 1 |
Kreher, S | 1 |
Parmentier, S | 1 |
Wolf, HH | 1 |
Bisping, G | 1 |
Kirschner, M | 1 |
Bergmann, F | 1 |
Schilling, K | 1 |
Brümmendorf, TH | 1 |
Petrides, PE | 1 |
Tiede, A | 1 |
Matzdorff, A | 1 |
Griesshammer, M | 1 |
Riess, H | 1 |
Koschmieder, S | 1 |
1 review available for tranexamic acid and Atypical Chronic Myeloid Leukemia
Article | Year |
---|---|
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis
Topics: Anticoagulants; Antineoplastic Agents; Blood Coagulation Factors; Blood Loss, Surgical; Blood Transf | 2016 |